Sputnik lite: Russian Deputy Envoy to India Roman Babushkin on Tuesday informed that Sputnik Lite Covid vaccine was undergoing through third phase of clinical trials. Sputnik Lite is a single-dose vaccine for Covid-19.
Also Read | Modi govt planning stimulus package for sectors affected by Covid 2.0
Speaking to ANI, the Russian envoy said: “Sputnik lite is undergoing through third phase of clinical trials.” He also hailed India for its vaccine manufacturing capacity. He said India is one of the leaders in the world in terms of the capacity of medicine production.
He also said that supplies of Sputnik V Covid vaccine were going on according to the contract obligations and schedules. “We are getting some more requests from other Indian companies and state governments and all proposals are being studied very carefully,” the deputy envoy said.
Russia’s Sputnik V is among the three vaccines India has approved for the vaccination drive. Dr. Reddy’s Laboratories has tied up with Sputnik to manufacture the vaccine here in India. So far, two consignments of Sputnik vaccine have come to India. First lot had come on May 1 and the second on May 16. The regulatory clearance from the Central Drugs Laboratory-Kasauli was given on May 13.
After the second batch had landed in Hyderabad, Nikolay Kudashev, Russian Ambassador to India, said: “Sputnik V is Russian-Indian vaccine. We expect that its production in India will be gradually increased up to 850 million doses per year…There are plans to introduce single-dose vaccine soon in India-Sputnik Lite.”
Dr Reddy’s launched Sputnik V in the Indian market on May 14. The first dose was administered in Hyderabad. The company has fixed the price for imported doses at ₹948, with 5 per cent GST per dose — total ₹995.4 per dose.
Never miss a story! Stay connected and informed with Mint.
Download
our App Now!!
